These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
569 related articles for article (PubMed ID: 21320609)
41. [Human positron emission tomography with oral 11C-vinpocetine]. Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922 [TBL] [Abstract][Full Text] [Related]
42. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort? Fan Z; Harold D; Pasqualetti G; Williams J; Brooks DJ; Edison P J Nucl Med; 2015 May; 56(5):707-13. PubMed ID: 25840980 [TBL] [Abstract][Full Text] [Related]
43. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [ Brody AL; Hubert R; Enoki R; Garcia LY; Mamoun MS; Okita K; London ED; Nurmi EL; Seaman LC; Mandelkern MA Neuropsychopharmacology; 2017 Jul; 42(8):1630-1639. PubMed ID: 28262740 [TBL] [Abstract][Full Text] [Related]
44. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246 [TBL] [Abstract][Full Text] [Related]
45. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases. Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722 [TBL] [Abstract][Full Text] [Related]
46. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging. Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M; Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188 [TBL] [Abstract][Full Text] [Related]
51. Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [ Wang Y; Coughlin JM; Ma S; Endres CJ; Kassiou M; Sawa A; Dannals RF; Petri M; Pomper MG Lupus; 2017 Feb; 26(2):170-178. PubMed ID: 27387599 [TBL] [Abstract][Full Text] [Related]
52. Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using Zanotti-Fregonara P; Kreisl WC; Innis RB; Lyoo CH J Nucl Med; 2019 Jul; 60(7):978-984. PubMed ID: 30655330 [TBL] [Abstract][Full Text] [Related]
53. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [ Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11)C-[R]-PK11195 PET. Kumar A; Muzik O; Shandal V; Chugani D; Chakraborty P; Chugani HT J Neuroinflammation; 2012 Oct; 9():232. PubMed ID: 23035793 [TBL] [Abstract][Full Text] [Related]
55. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. Arlicot N; Vercouillie J; Ribeiro MJ; Tauber C; Venel Y; Baulieu JL; Maia S; Corcia P; Stabin MG; Reynolds A; Kassiou M; Guilloteau D Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392 [TBL] [Abstract][Full Text] [Related]
56. Influence of alcoholism and cholesterol on TSPO binding in brain: PET [ Kim SW; Wiers CE; Tyler R; Shokri-Kojori E; Jang YJ; Zehra A; Freeman C; Ramirez V; Lindgren E; Miller G; Cabrera EA; Stodden T; Guo M; Demiral ŞB; Diazgranados N; Park L; Liow JS; Pike V; Morse C; Vendruscolo LF; Innis RB; Koob GF; Tomasi D; Wang GJ; Volkow ND Neuropsychopharmacology; 2018 Aug; 43(9):1832-1839. PubMed ID: 29777199 [TBL] [Abstract][Full Text] [Related]
57. Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans. Endres CJ; Pomper MG; James M; Uzuner O; Hammoud DA; Watkins CC; Reynolds A; Hilton J; Dannals RF; Kassiou M J Nucl Med; 2009 Aug; 50(8):1276-82. PubMed ID: 19617321 [TBL] [Abstract][Full Text] [Related]
58. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L Acta Neurol Scand; 2002 Dec; 106(6):325-32. PubMed ID: 12460136 [TBL] [Abstract][Full Text] [Related]
59. (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease. Kreisl WC; Lyoo CH; Liow JS; Wei M; Snow J; Page E; Jenko KJ; Morse CL; Zoghbi SS; Pike VW; Turner RS; Innis RB Neurobiol Aging; 2016 Aug; 44():53-61. PubMed ID: 27318133 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat. Yanamoto K; Yamasaki T; Kumata K; Yui J; Odawara C; Kawamura K; Hatori A; Inoue O; Yamaguchi M; Suzuki K; Zhang MR Synapse; 2009 Nov; 63(11):961-71. PubMed ID: 19593823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]